Search for: "Astra Zeneca" Results 41 - 60 of 63
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2010, 5:10 am
King Pharmaceuticals Inc. et al (Patent Docs) Famvir (Famciclovir) – US: Teva and Novartis settle patent litigation regarding Famciclovir (IP Factor) (SmartBrief) Gardasil, Silgard - Portugal: More on Gardasil and Silgard from Portugal (SPC Blog) Lipitor (Atorvastatin) – Philippines: UniLab can still sell generic version of Pfizer's Lipitor after a Makati court denies latter's petition for preliminary injunction (GenericsWeb) Mucinex (Guaifenesin) – US: W D Michigan rules… [read post]
20 Oct 2009, 1:15 am
Each company’s share of the $124 million total was as follows: Mylan and UDL : $118 million Astra-Zeneca : $2.6 million Orth-McNeil : $3.4 million Ãœber-relator Ven-A-Care, of Key West, Florida, will receive a share amounting to nearly $11 million. [read post]
6 Oct 2009, 4:00 am
AstraZeneca was formed through a 1999 merger between Britain's Zeneca Group PLC and Sweden's Astra AB, the parent of Astra USA.Corporate boards face mounting pressure to crack down on executives who breach their fiduciary duty, said Thomas C. [read post]
1 Oct 2009, 4:47 am
A number of plaintiffs have filed individual lawsuits against pain pump (I-Flow, Don Joy, Stryker, Moog, Breg, and others) and anesthetic drug manufacturers (Astra-Zeneca, Abbott, and others) after suffering catastrophic cartilage damage as a result of intra-articular injection of pain medications. [read post]
3 Aug 2009, 10:35 pm
Sun Pharmaceuticals has settled with Medimmune (Astra Zeneca ) concerning the (Hatch-Waxman) patent dispute over Ethyol (amifostine), a drug which is used to reduce toxicities associated with chemotherapy and radiation in head and neck cancers. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
9 Mar 2009, 4:44 am
Those companies surveyed by Towers Perrin are: Merck, Abbott Laboratories, Amgen, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman-LaRoche, Johnson & Johnson, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth.You'll notice that list contains 14 companies â€â [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
23 Oct 2008, 10:18 am
Kelly's departure appears to have been closely linked to Vice Chairman Karen Katen's decision to "reflect on both her professional and ...peterrost.blogspot.com/2007/01/pfizer-ceo-eliminates-karen-katen.html - 68k - Cached - Similar pages - Note thisMore results from peterrost.blogspot.com »And even if you want to find out about an old pharma CEO, like Astra-Zeneca's Lars Bildman, Google will give you the Peter Rost blog ranked #3:THE PETER ROST… [read post]
5 Sep 2008, 9:29 am
1 Former CEO in underwear (Astra-Zeneca's Bildman?)... [read post]
12 Jun 2008, 10:40 pm
Indeed, many of the large life sciences companies that have been targeted in securities suits in recent months – including, for example, Guidant, Pfizer and Astra Zeneca – have successfully managed to get the cases dismissed. [read post]
15 Apr 2008, 8:09 pm
Conference highlights include: Article 81: licensing, distribution arrangements, settlement agreements Article 82: the Astra/Zeneca case and its consequences for the pharmaceutical industry, plus lessons to be learned from Microsoft Restructuring distribution systems in Europe Analysis of patent actions in Europe European legislation initiatives: EPC 2000, EPLA and the Enforcement Directive Implementation of the New Medicines Legislation and adoption of the New Penalties… [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
15 Mar 2007, 9:25 am
In the case, patients, health insurance companies, and consumer advocacy groups are challenging the legality of a patent litigation settlement that included a $21 million payment from Astra Zeneca to Barr Labs and an agreement by Barr to delay marketing its generic tamoxifen product until Astra's patent expired. [read post]
8 Jan 2007, 5:49 am
If, hypothetically, one bought a patent-holding company (aka, patent trolls to some) does one become a troll? [read post]
19 Dec 2006, 11:33 am
Reuters reported: The European Patent Office [EPO] has revoked a key patent on AstraZeneca Plc's top-selling drug Nexium, the organization said on December 19. [read post]
14 Dec 2006, 9:42 pm
District Court for the District of Columbia, alleging that Astra Zeneca (AZ) illegally monopolized the market for its proton pump inhibitor drugs Prilosec, Nexium, and their AB-rated generic equivalents, by engaging in a scheme to convert the prescription drug market for Prilosec to Nexium. [read post]